Drug Shortage Report for ONIVYDE
| Report ID | 37169 |
| Drug Identification Number | 02467135 |
| Brand name | ONIVYDE |
| Common or Proper name | Irinotecan Liposome for Injection |
| Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRINOTECAN HYDROCHLORIDE |
| Strength(s) | 43MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVENOUS |
| Packaging size | Vials of 43g/10ML |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2018-01-23 |
| Actual start date | 2018-01-23 |
| Estimated end date | 2018-02-09 |
| Actual end date | 2018-02-12 |
| Shortage status | Resolved |
| Updated date | 2018-02-15 |
| Company comments | For emergency supply, please contact customer service at +1 844 423 2090 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
| Company contact information | medinfoandsafetycanada@ipsen.com 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2018-02-15 | French | Compare |
| v3 | 2018-02-15 | English | Compare |
| v2 | 2018-01-24 | French | Compare |
| v1 | 2018-01-24 | English | Compare |
Showing 1 to 4 of 4